Alain Faivre-Chauvet

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

Philip H. Elsinga, Sergio Todde, Iván Peñuelas et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 153 citations · Full text

Good Radiopharmacy Practice, Therapeutic Drug Monitoring, Engineering +15

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.

Françoise Kraeber‐Bodéré, Caroline Rousseau, Caroline Bodet‐Milin et al. · PubMed · 2006 · 127 citations

Antitumor Immunity Induced after α Irradiation

Jean‐Baptiste Gorin, Jérémie Ménager, Sébastien Gouard et al. · Neoplasia · 2014 · 98 citations · Full text

High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer

Éric Mirallié, J.-P. Vuillez, Stéphane Bardet et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 83 citations · Full text

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

Pierre‐Yves Salaün, L. Campion, Claire Bournaud et al. · Journal of Nuclear Medicine · 2012 · 80 citations · Full text